An anti-malarial drug, hydroxychloroquine, was used for mitigating SLE, RA, and COVID-19 by preventing ROS and IL-8 production and TLR-9 expression, although it remains unclear if it can inhibit the NET formation-related functions of PADs, MPO, and NE [132]. Here, MPO is linked to COVID-19.